SPIE, the International Society for Optics and Photonics, Announces Its 2026 Society Awards
Today, the Awards Committee of SPIE, the international society for optics and photonics, announced the recipients of its prestigious annual awards. Honoring transformative advancements across a range of professional areas — including medicine, astronomy, lithography, optical metrology, optical design, and community leadership — the Society's awards recognize technical accomplishments as well as committed service to SPIE and support of its organizational mission.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108227351/en/
SPIE, the international society for optics and photonics, awarded their Gold Medal to Maryellen Giger (pictured here with her team) for pioneering work in computer-aided diagnosis and image analysis/AI, significant impact on clinical translation, and supporting the next generation of medical-imaging scientists and the SPIE community.
SPIE Gold Medal: Maryellen Giger
For pioneering work in computer-aided diagnosis and image analysis/AI, significant impact on clinical translation, and supporting the next generation of medical-imaging scientists and the SPIE community.
SPIE President's Award: James Sydor
For visionary leadership, philanthropy, and service to SPIE and the precision optics community through advancements in optical fabrication, support of optics education, and professional training of current and future technicians.
SPIE Directors' Award: Xiao-Cong (Larry) Yuan and Anatoly Zayats
For exceptional leadership in founding the high-impact journal Advanced Photonics as co-editor-in-chiefs. Since 2019, the journal has showcased innovative research and raised the prestige of SPIE publishing.
SPIE Mozi Award: Hui Cao
For pioneering work in novel light sources, and demonstrating a wide range of applications in imaging, sensing, and random number generation.
SPIE Aden and Marjorie Meinel Technology Achievement Award: Sos Agaian
For pioneering contributions to computational perception-based image processing, particularly in blind image quality assessment and randomness measurement, leading to significant advancements in image editing and medical imaging.
SPIE A.E. Conrady Award in Optical Engineering: Ching-Cherng Sun
For outstanding optical engineering contributions in the advancement of design, development, and testing of solid-state LED lighting.
SPIE Biophotonics Technology Innovator Award: Jürgen Popp
For contributions to the clinical translation of Raman spectroscopy, enabling real-time, label-free diagnostics in oncology and infectious disease, and advancing biophotonics from concept to clinical application.
SPIE Britton Chance Biomedical Optics Award: Irving Bigio
For pioneering elastic scattering spectroscopy and translating it into a clinically impactful diagnostic tool, and for mentoring a generation of leaders in translational biomedical optics.
SPIE Chandra S. Vikram Award in Optical Metrology: James Burge
For lifetime achievement in optical metrology with astronomical instrumentation innovations, technology commercialization, and career-long mentorship, guidance, and team-building in the precision optics and astronomy communities.
SPIE Dennis Gabor Award in Diffractive Optics: Shin-Tson Wu
For pioneering contributions to large-angle liquid crystal polarization volume gratings and their widespread applications for augmented reality and virtual reality displays.
SPIE Diversity Outreach Award: Kimani Toussaint
For the promotion of inclusion, diversity, and equity in the development of biomedical diagnostics, in optics research and mentoring, and in public outreach and awareness.
SPIE Early Career Achievement Award — Academic Focus: Alex Walsh
For innovations in label-free optical microscopy through integration of fluorescence lifetime imaging and machine learning, and for outstanding mentorship and service contributions within the community.
SPIE Early Career Achievement Award — Industry/Government Focus: Amirhossein Ghods
For pioneering manufacturable, next-generation VCSEL platforms that advance quantum, biomedical, and dual-use sensing across industry and defense.
SPIE Frits Zernike Award for Microlithography: Andreas Erdmann
For contributions to the understanding and modeling of image formation and resist patterning in deep and EUV lithography, especially photomasks’ 3D effect, and for lithography education.
SPIE G. G. Stokes Award in Optical Polarization: Siddharth Ramachandran
For seminal contributions in the area of spatially and vectorially structured light in optical fibers.
SPIE Harold E. Edgerton Award in High-Speed Optics: Peter Delfyett
For pioneering contributions to the field of low-noise, high-power, ultrafast semiconductor lasers and their commercial applications.
SPIE Harrison H. Barrett Award in Medical Imaging: Norbert Pelc
For defining the fields of X-ray, CT, and MR imaging for over 40 years, impacting clinical care, and inspiring, nurturing, and encouraging generations of clinicians and scientists.
SPIE Maiman Laser Award: Edik Rafailov
For pioneering contributions to high-power aluminum-free diode lasers and ultrafast quantum dot laser technology, and their transformative impact on non-linear optics and biomedical photonics.
SPIE Maria Goeppert Mayer Award in Photonics: Carmen Menoni
For pioneering innovations in extreme ultraviolet photonics, the research and development of advanced amorphous oxide coatings for laser science, and community leadership.
SPIE María J. Yzuel Educator Award: Bahaa Saleh
For significant contributions to education in optics, photonics, and image science.
SPIE George W. Goddard Award in Space and Airborne Optics: Lee Feinberg
For outstanding leadership through the design, integration, and delivery of optical systems that brought the objectives of the Webb and Hubble space telescopes into clear focus.
The complete listing of the SPIE Society Awards and their recipients is available here.
About SPIE
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, we have invested more than $26 million in the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260108227351/en/
Contacts
Lindsey McGuirk
Public Relations Manager
lindseym@spie.org
+1 360 685 5443
@spie.org -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbsky.app%2Fpro
file%2Fspie.org&esheet=54391579&newsitemid=20260108227351&lan=en-US&anchor=%40sp
ie.org&index=25&md5=cd9a04250727850b5b66ba1782315434
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press Release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press Release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press Release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press Release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press Release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom